scl-8k_20210218.htm
false 0000094049 0000094049 2021-02-18 2021-02-18

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): 02/18/2021

 

STEPAN COMPANY

(Exact name of registrant as specified in its charter)

 

Commission File Number: 1-4462

 

Delaware

 

36-1823834

(State or other jurisdiction of

incorporation)

 

(IRS Employer

Identification No.)

Edens and Winnetka Road, Northfield, Illinois 60093

(Address of principal executive offices, including zip code)

(847)446-7500

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Title of each class

 

 

Trading Symbol(s)

 

Name of Each exchange on which registered

 

Common Stock, $1 par value

 

SCL

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

 

 


 

 

Item 2.02.Results of Operations and Financial Condition

 

On February 18, 2021, Stepan Company (“Stepan”) issued a press release providing its financial results for the fourth quarter and full year ended December 31, 2020.  A copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.

 

In addition, on February 18, 2021, Stepan issued a press release announcing that its Board of Directors declared a quarterly cash dividend on its common stock of $0.305 per share.  The dividend will be paid on March 15, 2021, to common stockholders of record on March 5, 2021.  A copy of the press release is attached as Exhibit 99.2 hereto and incorporated herein by reference.

 

Item 9.01.Financial Statements and Exhibits

 

(d)

Exhibits

 

Exhibit Number: 99.1

Description: Press Release of Stepan Company dated February 18, 2021

 

Exhibit Number: 99.2

Description: Press Release of Stepan Company dated February 18, 2021

 

Exhibit Number:  104

Description:  Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

 


 

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

STEPAN COMPANY

Date: February 18, 2021

 

 

 

 

By:

 

 

/s/ David G. Kabbes

 

 

 

 

 

 

David G. Kabbes

 

 

 

 

 

 

Vice President, General Counsel and Secretary

 

 

scl-ex991_7.htm

 

 

Exhibit 99.1

 

Stepan Reports Record Fourth Quarter Results and Full Year 2020 Earnings

 

Northfield, Illinois, February 18, 2021 -- Stepan Company (NYSE: SCL) today reported:

 

Fourth Quarter Highlights

 

 

Reported net income was $30.4 million, or $1.30 per diluted share versus $22.0 million, or $0.95 per diluted share, in the prior year.  Adjusted net income* was $33.1 million, or $1.42 per diluted share versus $25.7 million, or $1.10 per diluted share, in the prior year.  Total Company sales volume increased 7% versus the prior year.  

 

 

 

Surfactant operating income was $43.3 million versus $33.9 million in the prior year. This increase was primarily attributable to an 8% increase in global sales volume as well as improved product and customer mix.  The sales volume growth was principally due to higher demand for cleaning, disinfection and personal wash products as a result of COVID-19.

 

 

 

Polymer operating income was $22.8 million versus $11.4 million in the prior year. This increase was mostly attributable to an insurance recovery related to the first quarter 2020 Millsdale, IL plant power outage and a 7% increase in global Polymer sales volume versus prior year.  Global rigid polyol volume growth of 10%, principally in Europe, more than offset lower demand within the phthalic anhydride business.

 

 

 

The Company recognized a final $13.0 million pre-tax insurance recovery related to the first quarter 2020 Millsdale, IL plant power outage.  Surfactant and Polymer operating income benefited $3.0 million and $10.0 million, respectively, in the fourth quarter.  All expenses, business interruptions and insurance recoveries associated with the Millsdale power outage were captured in the full year 2020.  

 

 

 

Specialty Product operating income was $5.2 million versus $5.0 million in the prior year.  This slight improvement reflects a more favorable product mix during the current year quarter.  

 

 

 

As previously announced, the Company acquired INVISTA’s aromatic polyester polyol business and associated assets on January 29, 2021.  The transaction included two manufacturing sites, one in Wilmington, NC (United States) and the other in Vlissingen (the Netherlands).  The Company believes that INVISTA’S available spare capacity, combined with debottlenecking opportunities in both plants, will allow Stepan to support future market growth in a capital efficient way.  The Company recognized one-time tax costs of $2.8 million for cash repatriations related to this acquisition in the fourth quarter. The acquired business has global sales of approximately $100.0 million.

 

 

Full Year Highlights

 

 

Reported net income was a record $126.8 million, or $5.45 per diluted share, versus $103.1 million, or $4.42 per diluted share, in the prior year.  Adjusted net income* was a record $132.0 million, or $5.68 per diluted share, versus $119.4 million, or $5.12 per diluted share, in the prior year.  Total Company sales volume reached a record high, up 3% versus the prior year.  

 

 

1


 

The Surfactant segment delivered record operating income of $169.1 million, up 38% versus prior year.  This earnings growth was driven by a 6% increase in global sales volume due to higher demand for cleaning, disinfection and personal wash products as a result of COVID-19.  The Polymer segment delivered $68.2 million of operating income, down 2% versus prior year. Global Polymer sales volume was down 5% as a result of construction project delays and cancellations due to COVID-19 and lower demand within the phthalic anhydride business.  Specialty Product operating income was $14.0 million versus $16.4 million in the prior year.

 

 

 

The Company had negative net debt at year-end as cash balances of $349.9 million exceeded total debt of $198.7 million.

 

 

 

The effect of foreign currency translation negatively impacted net income by $5.7 million, or $0.24 per diluted share, versus the prior year.

 

 

*

Adjusted net income is a non-GAAP measure which excludes deferred compensation income/expense, cash-settled stock appreciation rights (SARs) income/expense, as well as other significant and infrequent/non-recurring items. See Table II for reconciliations of non-GAAP adjusted net income and adjusted earnings per diluted share.

 

 

 

“As the world continues to be challenged by the global pandemic, we at Stepan remain committed to do our part by supporting customers that supply essential cleaning, disinfection and personal wash products to the market.  We are extremely grateful to our employees for their passion and commitment to get the job done for our customers throughout this challenging year,” said F. Quinn Stepan, Jr., Chairman and Chief Executive Officer.

 

“Despite significant challenges during the year, inclusive of the global pandemic and the first quarter 2020 plant power outage at our Millsdale, IL facility, the Company delivered record fourth quarter and full year earnings.  Both full year adjusted net income and adjusted EPS were up 11% versus the prior year.  Surfactant fourth quarter operating income was up 28% on the strength of 8% volume growth, which was mostly attributable to strong demand in consumer product end markets driven by the fight against the COVID-19 virus.  Our Polymer business was up significantly during the quarter due to the Millsdale insurance recovery.  Excluding the insurance recovery, our Polymer business was up 12% due to strong European rigid polyol growth.  Our Specialty Product business results were up slightly in the fourth quarter.”

 

“During January 2021 we purchased INVISTA’s aromatic polyester polyol business and associated assets.  We are excited to add INVISTA’s polyester polyol business, including its manufacturing sites, employees and customers to Stepan.”

 

 

 

 

 

 

 

 

 

 

 

 

2


Financial Summary

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

($ in thousands, except per share data)

2020

 

 

2019

 

 

%

Change

 

 

2020

 

 

2019

 

 

%

Change

 

Net Sales

$

494,734

 

 

$

444,990

 

 

 

11

%

 

$

1,869,750

 

 

$

1,858,745

 

 

 

1

%

Operating Income

$

44,500

 

 

$

28,491

 

 

 

56

%

 

$

171,522

 

 

$

127,260

 

 

 

35

%

Net Income Attributable to Stepan

$

30,350

 

 

$

22,038

 

 

 

38

%

 

$

126,770

 

 

$

103,129

 

 

 

23

%

Earnings per Diluted Share

$

1.30

 

 

$

0.95

 

 

 

37

%

 

$

5.45

 

 

$

4.42

 

 

 

23

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income *

$

33,120

 

 

$

25,692

 

 

 

29

%

 

$

132,014

 

 

$

119,387

 

 

 

11

%

Adjusted Earnings per Diluted Share *

$

1.42

 

 

$

1.10

 

 

 

29

%

 

$

5.68

 

 

$

5.12

 

 

 

11

%

 

* See Table II for reconciliations of non-GAAP adjusted net income and earnings per diluted share.

 

 

Summary of Fourth Quarter Adjusted Net Income Items

 

Adjusted net income excludes non-operational deferred compensation income/expense, cash-settled SARs income/expense and other significant and infrequent/non-recurring items.

 

 

Deferred Compensation:  The fourth quarter includes $2.3 million of after-tax expense versus $1.5 million of after-tax expense in the prior year.

 

 

Cash-Settled SARs:  These management incentive instruments provide cash to participants equal to the appreciation on the price of specified shares of Company stock over a specified period of time.  Because income or expense is recognized merely on the movement in the price of Company stock it has been excluded, similar to deferred compensation, to arrive at adjusted net income.  The current year fourth quarter includes $0.1 million of after-tax expense versus $0.3 million of after-tax expense in the prior year.

 

 

Business Restructuring:  The fourth quarter includes $0.4 million of after-tax decommissioning expense related to the Company’s Canadian plant closure versus $0.8 million of after-tax expense in 2019.  The fourth quarter 2019 expense includes both Canadian plant closure and Germany sulfonation shutdown costs.  

 

 

Percentage Change in Net Sales

 

Net sales in the fourth quarter increased 11% year-over-year due to a 7% increase in global sales volume and improved product and customer mix.  The sales volume improvement reflects Surfactant and Polymer sales growth of 8% and 7%, respectively.  The unfavorable impact of foreign currency translation negatively impacted net sales by 2%.     

 

 

Three Months Ended

December 31, 2020

 

 

Twelve Months Ended

December 31, 2020

 

Volume

 

 

7

%

 

 

3

%

Selling Price & Mix

 

 

6

%

 

 

 

Foreign Translation

 

 

(2

)%

 

 

(2

)%

Total

 

 

11

%

 

 

1

%

 

 

 

 

3


Segment Results

 

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

($ in thousands)

 

2020

 

 

2019

 

 

%

Change

 

 

2020

 

 

2019

 

 

%

Change

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Surfactants

 

$

358,441

 

 

$

309,974

 

 

 

16

%

 

$

1,351,686

 

 

$

1,272,723

 

 

 

6

%

Polymers

 

$

116,695

 

 

$

116,443

 

 

 

0

%

 

$

452,277

 

 

$

512,347

 

 

 

(12

)%

Specialty Products

 

$

19,598

 

 

$

18,573

 

 

 

6

%

 

$

65,787

 

 

$

73,675

 

 

 

(11

)%

Total Net Sales

 

$

494,734

 

 

$

444,990

 

 

 

11

%

 

$

1,869,750

 

 

$

1,858,745

 

 

 

1

%

 

 

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

($ in thousands, all amounts pre-tax)

 

2020

 

 

2019

 

 

%

Change

 

 

2020

 

 

2019

 

 

%

Change

 

Operating Income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Surfactants

 

$

43,291

 

 

$

33,867

 

 

 

28

%

 

$

169,101

 

 

$

122,780

 

 

 

38

%

Polymers

 

$

22,784

 

 

$

11,419

 

 

 

100

%

 

$

68,214

 

 

$

69,567

 

 

 

(2

)%

Specialty Products

 

$

5,163

 

 

$

5,041

 

 

 

2

%

 

$

13,966

 

 

$

16,415

 

 

 

(15

)%

Segment Operating Income

 

$

71,238

 

 

$

50,327

 

 

 

42

%

 

$

251,281

 

 

$

208,762

 

 

 

20

%

Corporate Expenses

 

$

(26,738

)

 

$

(21,836

)

 

 

22

%

 

$

(79,759

)

 

$

(81,502

)

 

 

(2

)%

    Consolidated Operating Income

 

$

44,500

 

 

$

28,491

 

 

 

56

%

 

$

171,522

 

 

$

127,260

 

 

 

35

%

 

Total segment operating income increased $20.9 million, or 42%, versus the prior year quarter.  Full year segment operating income increased $42.5 million, or 20%, versus the prior year.    

 

 

Surfactant net sales were $358.4 million for the quarter, a 16% increase versus the prior year.  Sales volume increased 8% mostly due to higher demand for products sold into the consumer product end markets, driven by increased demand for cleaning, disinfection and personal wash products as a result of COVID-19.  Higher sales volume to our Tier 2/3 customers also contributed to this increase.  This growth was partially offset by lower demand in the agricultural and oilfield markets.  Selling prices were up 11% and the translation impact of a stronger U.S. dollar negatively impacted net sales by 3%.  The higher selling prices primarily reflect improved product and customer mix.  Surfactant operating income for the quarter increased $9.4 million, or 28%, versus the prior year primarily due to the strong sales volume growth and a $3.0 million insurance recovery related to the first quarter 2020 Millsdale, IL plant power outage.  

 

 

Polymer net sales were $116.7 million in the fourth quarter, essentially flat versus prior year.  Total sales volume increased 7%, primarily due to 10% growth in global rigid polyol demand, principally in Europe.  Lower phthalic anhydride demand partially offset the above growth.  Selling prices declined 8% and foreign currency translation positively impacted net sales by 1%.  Polymer fourth quarter operating income increased $11.4 million, or 100%, versus the prior year quarter due to the $10.0 million insurance recovery related to the first quarter 2020 Millsdale, IL plant power outage and sales volume growth.

 

Specialty Product net sales were $19.6 million for the quarter, a 6% increase versus the prior year.  Sales volume was down 1% between quarters and operating income improved 2%.  

4


Corporate Expenses

 

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

($ in thousands)

 

2020

 

 

2019

 

 

%

Change

 

 

2020

 

 

2019

 

 

%

Change

 

Total  -  Corporate Expenses

 

$

26,738

 

 

$

21,836

 

 

 

22

%

 

$

79,759

 

 

$

81,502

 

 

 

(2

)%

Less:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    Deferred Compensation Expense

 

$

5,234

 

 

$

3,662

 

 

 

43

%

 

$

9,988

 

 

$

15,140

 

 

 

(34

)%

    Business Restructuring

 

$

504

 

 

$

1,102

 

 

 

(54

)%

 

$

1,212

 

 

$

2,744

 

 

 

(56

)%

Adjusted Corporate Expense

 

$

21,000

 

 

$

17,072

 

 

 

23

%

 

$

68,559

 

 

$

63,618

 

 

 

8

%

 

* See Table III for a discussion of deferred compensation plan accounting.

    

Corporate expenses, excluding deferred compensation and business restructuring expenses, increased $3.9 million, or 23%, versus the prior year quarter.  This quarterly increase was primarily attributable to higher incentive-based compensation and acquisition-related expenses.   

 

 

Income Taxes

 

The Company’s full year effective tax rate was 25.4% in 2020 compared to 18.1% in 2019.  This year-over-year increase was primarily attributable to: (i) the non-recurrence of favorable research and development tax credits recognized in the third quarter of 2019; (ii) a non-recurring unfavorable tax cost in the fourth quarter of 2020 related to cash repatriations to facilitate the INVISTA acquisition, and (iii) a less favorable geographical mix of income in 2020 versus 2019.    

 

 

Shareholder Return

 

The Company paid $6.9 million of dividends to shareholders in the fourth quarter of 2020.  For the full year the Company paid $25.4 million of dividends and repurchased $15.3 million of Company stock.  The Company has 175,874 shares remaining under its Board of Directors’ share repurchase authorization.  With the increased cash dividend in the fourth quarter of 2020, the Company has increased its dividend on the Company’s common stock for the 53rd consecutive year.

 

 

Selected Balance Sheet Information

 

The Company’s net debt level decreased $48.7 million versus the third quarter of 2020 while the net debt ratio dropped from -12% to -18%, reflecting cash balances in excess of total debt.  The decrease in net debt was attributable to a $39.5 million increase in cash and lower debt due to scheduled principal repayments.  

 

5


($ in millions)

12/31/20

 

 

9/30/20

 

 

6/30/20

 

 

3/31/20

 

 

12/31/19

 

Net Debt

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Debt

$

198.7

 

 

$

207.9

 

 

$

207.9

 

 

$

222.1

 

 

$

222.1

 

Cash

 

349.9

 

 

 

310.4

 

 

 

272.9

 

 

 

254.3

 

 

 

315.4

 

Net Debt

$

(151.2

)

 

$

(102.5

)

 

$

(65.0

)

 

$

(32.2

)

 

$

(93.3

)

Equity

 

986.7

 

 

 

938.2

 

 

 

897.4

 

 

 

866.8

 

 

 

891.8

 

Net Debt + Equity

$

835.5

 

 

$

835.7

 

 

$

832.4

 

 

$

834.6

 

 

$

798.5

 

Net Debt / (Net Debt + Equity)

 

-18

%

 

 

-12

%

 

 

-8

%

 

 

-4

%

 

 

-12

%

 

 

 

The major working capital components were:

 

($ in millions)

12/31/20

 

 

9/30/20

 

 

6/30/20

 

 

3/31/20

 

 

12/31/19

 

Net Receivables

$

301.3

 

 

$

295.6

 

 

$

286.7

 

 

$

290.6

 

 

$

276.8

 

Inventories

 

218.8

 

 

 

202.3

 

 

 

208.2

 

 

 

198.2

 

 

 

203.6

 

Accounts Payable

 

(236.8

)

 

 

(207.6

)

 

 

(187.4

)

 

 

(187.9

)

 

 

(194.3

)

 

$

283.3

 

 

$

290.3

 

 

$

307.5

 

 

$

300.9

 

 

$

286.1

 

 

The Company had full year capital expenditures of $125.8 million in 2020 versus $105.6 million in the prior year.

 

 

2021 Outlook

 

“Adjusted net income for 2020 was a record $132.0 million, up 11% versus 2019,” said F. Quinn Stepan, Jr., Chairman and Chief Executive Officer. “Looking forward, we believe our Surfactant volumes in the consumer product end markets should remain strong as a result of continued heightened demand for disinfection, cleaning and personal wash products.  We anticipate that demand for surfactants within the agricultural and oilfield markets will improve slightly in 2021.  Global demand for rigid polyols has slowly recovered from pandemic-related delays and cancellations of re-roofing and new construction projects.  We anticipate that demand will continue to recover at a modest pace in 2021.  Despite recent challenges, we believe the long-term prospects for rigid polyols remain attractive as energy conservation efforts and more stringent building codes should increase demand.  We believe our acquisition of INVISTA’s aromatic polyester polyol business and two manufacturing sites positions us to meet long term demand growth.  We anticipate our Specialty Product business results will improve slightly year-over-year.”  

 

 

Conference Call

 

Stepan Company will host a conference call to discuss its fourth quarter and full year 2020 results at 10:00 a.m. ET (9:00 a.m. CT) on February 18, 2021. The call can be accessed by phone and webcast. Telephone access will be available by dialing +1 (800) 897-4933, and the webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call.

 

Supporting Slides

 

Slides supporting this press release will be made available at www.stepan.com through the Investor/Presentations page at approximately the same time as this press release is issued.

6


Corporate Profile

 

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection compounds and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

 

Headquartered in Northfield, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

 

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

 

More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com

 

Contact: Luis E. Rojo 847-446-7500

 

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

 

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

 

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

7


Table I

STEPAN COMPANY

For the Three and Twelve Months Ended December 31, 2020 and 2019

(Unaudited – in thousands, except per share data)

 

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Net Sales

 

$

494,734

 

 

$

444,990

 

 

$

1,869,750

 

 

$

1,858,745

 

Cost of Sales

 

 

385,942

 

 

 

360,246

 

 

 

1,486,137

 

 

 

1,519,031

 

Gross Profit

 

 

108,792

 

 

 

84,744

 

 

 

383,613

 

 

 

339,714

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling

 

 

15,824

 

 

 

14,661

 

 

 

55,543

 

 

 

56,956

 

Administrative

 

 

26,405

 

 

 

22,019

 

 

 

87,362

 

 

 

82,577

 

Research, Development and Technical Services

 

 

16,325

 

 

 

14,809

 

 

 

57,986

 

 

 

55,037

 

Deferred Compensation Expense

 

 

5,234

 

 

 

3,662

 

 

 

9,988

 

 

 

15,140

 

 

 

 

63,788

 

 

 

55,151

 

 

 

210,879

 

 

 

209,710

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Business Restructuring

 

 

504

 

 

 

1,102

 

 

 

1,212

 

 

 

2,744

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

 

 

44,500

 

 

 

28,491

 

 

 

171,522

 

 

 

127,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest, Net

 

 

(1,294

)

 

 

(911

)

 

 

(5,409

)

 

 

(5,932

)

Other, Net

 

 

1,150

 

 

 

306

 

 

 

4,954

 

 

 

4,571

 

 

 

 

(144

)

 

 

(605

)

 

 

(455

)

 

 

(1,361

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income Before Income Taxes

 

 

44,356

 

 

 

27,886

 

 

 

171,067

 

 

 

125,899

 

Provision for Income Taxes

 

 

13,424

 

 

 

5,853

 

 

 

43,411

 

 

 

22,798

 

Net Income

 

 

30,932

 

 

 

22,033

 

 

 

127,656

 

 

 

103,101

 

Net (Income) Loss Attributable to Noncontrolling Interests

 

 

(582

)

 

 

5

 

 

 

(886

)

 

 

28

 

Net Income Attributable to Stepan Company

 

$

30,350

 

 

$

22,038

 

 

$

126,770

 

 

$

103,129

 

Net Income Per Common Share Attributable to Stepan Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

1.32

 

 

$

0.96

 

 

$

5.52

 

 

$

4.47

 

Diluted

 

$

1.30

 

 

$

0.95

 

 

$

5.45

 

 

$

4.42

 

Shares Used to Compute Net Income Per Common

Share Attributable to Stepan Company

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

22,942

 

 

 

23,005

 

 

 

22,949

 

 

 

23,054

 

Diluted

 

 

23,316

 

 

 

23,302

 

 

 

23,256

 

 

 

23,316

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8


Table II

 

 

Reconciliation of Non-GAAP Net Income and Earnings per Diluted Share *

 

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

($ in thousands, except per share amounts)

 

2020

 

 

EPS

 

 

2019

 

 

EPS

 

 

2020

 

 

EPS

 

 

2019

 

 

EPS

 

Net Income Reported

 

$

30,350

 

 

$

1.30

 

 

$

22,038

 

 

$

0.95

 

 

$

126,770

 

 

$

5.45

 

 

$

103,129

 

 

$

4.42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred Compensation (Income) Expense

 

$

2,312

 

 

$

0.10

 

 

$

1,465

 

 

$

0.06

 

 

$

4,004

 

 

$

0.17

 

 

$

7,947

 

 

$

0.34

 

Business Restructuring Expense

 

$

379

 

 

$

0.02

 

 

$

806

 

 

$

0.04

 

 

$

905

 

 

$

0.04

 

 

$

2,005

 

 

$

0.09

 

Cash-Settled SARs (Income) Expense

 

$

79

 

 

$

0.00

 

 

$

325

 

 

$

0.01

 

 

$

335

 

 

$

0.02

 

 

$

2,090

 

 

$

0.09

 

Environmental Remediation Expense

 

$

-

 

 

$

-

 

 

$

1,058

 

 

$

0.04

 

 

 

 

 

 

$

-

 

 

$

3,268

 

 

$

0.14

 

Voluntary Debt Prepayment Expense

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

 

 

 

 

$

-

 

 

$

948

 

 

$

0.04

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income

 

$

33,120

 

 

$

1.42

 

 

$

25,692

 

 

$

1.10

 

 

$

132,014

 

 

$

5.68

 

 

$

119,387

 

 

$

5.12

 

 

* All amounts in this table are presented after-tax

 

The Company believes that certain measures that are not in accordance with generally accepted accounting principles (GAAP), when presented in conjunction with comparable GAAP measures, are useful for evaluating the Company’s operating performance and provide better clarity on the impact of non-operational items.  Internally, the Company uses this non-GAAP information as an indicator of business performance and evaluates management’s effectiveness with specific reference to these indicators.  These measures should be considered in addition to, and are neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP.

 

Reconciliation of Pre-Tax to After-Tax Adjustments

 

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

($ in thousands, except per share amounts)

 

2020

 

 

EPS

 

 

2019

 

 

EPS

 

 

2020

 

 

EPS

 

 

2019

 

 

EPS

 

Pre-Tax Adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred Compensation (Income) Expense

 

$

3,041

 

 

 

 

 

 

$

1,927

 

 

 

 

 

 

$

5,268

 

 

 

 

 

 

$

10,456

 

 

 

 

 

Business Restructuring Expense

 

$

504

 

 

 

 

 

 

$

1,102

 

 

 

 

 

 

$

1,212

 

 

 

 

 

 

$

2,744

 

 

 

 

 

Cash-Settled SARs (Income) Expense

 

$

104

 

 

 

 

 

 

$

427

 

 

 

 

 

 

$

441

 

 

 

 

 

 

$

2,749

 

 

 

 

 

Environmental Remediation Expense

 

$

-

 

 

 

 

 

 

$

1,392

 

 

 

 

 

 

$

-

 

 

 

 

 

 

$

4,300

 

 

 

 

 

Voluntary Debt Prepayment Expense

 

$

-

 

 

 

 

 

 

$

-

 

 

 

 

 

 

$

-

 

 

 

 

 

 

$

1,247

 

 

 

 

 

   Total Pre-Tax Adjustments

 

$

3,649

 

 

 

 

 

 

$

4,848

 

 

 

 

 

 

$

6,921

 

 

 

 

 

 

$

21,496

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cumulative Tax Effect on Adjustments

 

$

(879

)

 

 

 

 

 

$

(1,194

)

 

 

 

 

 

$

(1,677

)

 

 

 

 

 

$

(5,238

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

After-Tax Adjustments

 

$

2,770

 

 

$

0.12

 

 

$

3,654

 

 

$

0.15

 

 

$

5,244

 

 

$

0.23

 

 

$

16,258

 

 

$

0.70

 

9


 

Table III

 

 

Deferred Compensation Plan

 

 

The full effect of the deferred compensation plan on quarterly pre-tax income was $3.0 million of expense versus $1.9 million of expense in the prior year.  The full year pre-tax impact was $5.3 million of expense versus $10.5 million of expense in the prior year. The accounting for the deferred compensation plan results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The quarter end market prices of Company common stock are as follows:

 

 

2020

 

 

2019

 

 

 

12/31

 

 

9/30

 

 

6/30

 

 

3/31

 

 

12/31

 

 

9/30

 

 

6/30

 

 

3/31

 

Stepan Company

 

$

119.32

 

 

$

109.00

 

 

$

97.10

 

 

$

88.46

 

 

$

102.44

 

 

$

97.06

 

 

$

91.91

 

 

$

87.52

 

 

 

The deferred compensation income statement impact is summarized below:

 

 

Three Months Ended

December 31

 

 

Twelve Months Ended

December 31

 

($ in thousands)

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Deferred Compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income (Expense)

 

$

(5,234

)

 

$

(3,662

)

 

$

(9,988

)

 

$

(15,140

)

Other, net – Mutual Fund Gain (Loss)

 

 

2,193

 

 

 

1,735

 

 

 

4,720

 

 

 

4,684

 

Total Pretax

 

$

(3,041

)

 

$

(1,927

)

 

$

(5,268

)

 

$

(10,456

)

Total After Tax

 

$

(2,312

)

 

$

(1,465

)

 

$

(4,004

)

 

$

(7,947

)

 

 

 

 


10


Table IV

 

 

Effects of Foreign Currency Translation

 

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign currency exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results).  The table below presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the three and twelve month periods ending December 31, 2020 as compared to 2019:

 

($ in millions)

 

Three Months Ended

December 31

 

 

Increase

 

 

Change

Due to Foreign

Currency

Translation

 

 

Twelve Months Ended

December 31

 

 

Increase

 

 

Change

Due to Foreign

Currency

Translation

 

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

 

Net Sales

 

$

494.7

 

 

$

445.0

 

 

$

49.7

 

 

$

(7.5

)

 

$

1,869.8

 

 

$

1,858.7

 

 

$

11.1

 

 

$

(45.7

)

Gross Profit

 

 

108.8

 

 

 

84.7

 

 

 

24.1

 

 

 

(1.8

)

 

 

383.6

 

 

 

339.7

 

 

 

43.9

 

 

 

(10.2

)

Operating Income

 

 

44.5

 

 

 

28.5

 

 

 

16.0

 

 

 

(1.5

)

 

 

171.5

 

 

 

127.3

 

 

 

44.2

 

 

 

(7.7

)

Pretax Income

 

 

44.4

 

 

 

27.9

 

 

 

16.5

 

 

 

(1.4

)

 

 

171.1

 

 

 

125.9

 

 

 

45.2

 

 

 

(7.6

)

 

.

 

 

 


11


Table V

 

 

Stepan Company

Consolidated Balance Sheets

December 31, 2020 and December 31, 2019

 

 

December 31, 2020

 

 

December 31, 2019

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

$

905,651

 

 

$

818,789

 

Property, Plant & Equipment, Net

 

 

682,667

 

 

 

639,317

 

Other Assets

 

 

164,018

 

 

 

121,261

 

Total Assets

 

$

1,752,336

 

 

$

1,579,367

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities

 

$

416,554

 

 

$

339,114

 

Deferred Income Taxes

 

 

20,745

 

 

 

23,391

 

Long-term Debt

 

 

160,812

 

 

 

198,532

 

Other Non-current Liabilities

 

 

165,860

 

 

 

125,834

 

Total Stepan Company Stockholders’ Equity

 

 

986,693

 

 

 

891,783

 

Noncontrolling Interest

 

 

1,672

 

 

 

713

 

Total Liabilities and Stockholders’ Equity

 

$

1,752,336

 

 

$

1,579,367

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12

scl-ex992_17.htm

Exhibit 99.2

 

 

Stepan Declares Quarterly Dividend

 

Northfield, Illinois, February 18, 2021 -- Stepan Company (NYSE:SCL) today reported:

 

On February 17, 2021, the Board of Directors of Stepan Company declared a quarterly cash dividend on the Company’s common stock of $0.305 per share.  The dividend is payable on March 15, 2021, to common stockholders of record on March 5, 2021.  The Company increased its quarterly cash dividend in the fourth quarter of 2020 by $0.03 per share, marking the 53rd consecutive year that the Company has increased its cash dividend to stockholders.

 

Corporate Profile

 

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

 

Headquartered in Northfield, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

 

The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com

 

More information about Stepan’s sustainability program can be found on the Sustainability page at www.stepan.com

 

Contact: Luis E. Rojo 847-446-7500

 

Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company’s plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company’s actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “guidance,” “predict,” “potential,” “continue,” “likely,” “will,” “would,” “should,” “illustrative” and


variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements.

 

There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to the impact of the COVID-19 pandemic; accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants.

 

These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.